Atypical chest pain provides a diagnostic dilemma
Persistent pain leads a patient to re-present repeatedly and proves to be a challenging diagnostic and management dilemma.
Persistent pain leads a patient to re-present repeatedly and proves to be a challenging diagnostic and management dilemma.
The COSMOS trial shows the therapy is effective in patients who have failed an anti-TNF, researchers report.
Researchers say their study is the first to characterise X-linked hypophosphataemia over the lifespan.
Monotherapy gave the best outcomes in an analysis of data from three registries.
Trial findings suggest patients in remission might benefit from a more flexible approach to management of therapy, researchers say.
Patients are nearly six times more likely to make antibodies to the SARS-CoV-2 spike protein if taken off the therapy, researchers say.
The move follows a global drain on supplies of the biologic, which is in demand to treat patients hospitalised with COVID-19, says Professor Cather…
The data from nearly 1400 US patients should allay patients' fears, researchers say.
An early treat-to-target strategy should improve fatigue as it seems to go hand-in-hand with disease activity, researchers say.
The biologic has become scarce worldwide because of its use for COVID-19, the manufacturer says.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.